---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-002071"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T06:32:47.158291+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Citius Pharma raises ~$3M in registered direct offering of stock and warrants

## Summary
- Offering of 743,496 shares plus warrants for 743,496 shares at combined price of $4.035 per unit.
- Warrants exercisable at $4.035/share (8-K) or $3.91/share (press release), expire in 5 years.
- Net proceeds ~$2.7M after fees; intended for clinical development and working capital.
- H.C. Wainwright placement agent with 7% cash fee, $50k legal, $35k expense, and 52,045 placement agent warrants at $5.0438.
- Offering closed January 8, 2025 under effective shelf registration statement.

## SEC filing metadata
- accession: 0001213900-25-002071
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/0001213900-25-002071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390025002071/ea0227130-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-002071
- JSON: https://secwatch.observer/filing/0001213900-25-002071.json
- Plain text: https://secwatch.observer/filing/0001213900-25-002071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.